Free Trial

ATI Physical Therapy (ATIP) Competitors

ATI Physical Therapy logo
$1.03 0.00 (0.00%)
As of 07/18/2025

ATIP vs. ENZ, BRTX, BGLC, MGRX, SSY, ACON, DHAC, NIVF, OTRK, and BACK

Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include Enzo Biochem (ENZ), Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Aclarion (ACON), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), Ontrak (OTRK), and IMAC (BACK). These companies are all part of the "healthcare" industry.

ATI Physical Therapy vs. Its Competitors

Enzo Biochem (NYSE:ENZ) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

In the previous week, Enzo Biochem's average media sentiment score of 0.00 equaled ATI Physical Therapy'saverage media sentiment score.

Company Overall Sentiment
Enzo Biochem Neutral
ATI Physical Therapy Neutral

Enzo Biochem has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of -0.15, indicating that its share price is 115% less volatile than the S&P 500.

Enzo Biochem has higher earnings, but lower revenue than ATI Physical Therapy.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enzo Biochem$29.09M0.59-$26.08MN/AN/A
ATI Physical Therapy$741.86M0.01-$69.79M-$19.42-0.05

36.9% of Enzo Biochem shares are held by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are held by institutional investors. 11.4% of Enzo Biochem shares are held by insiders. Comparatively, 3.3% of ATI Physical Therapy shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

ATI Physical Therapy has a net margin of -7.79% compared to Enzo Biochem's net margin of -75.34%. ATI Physical Therapy's return on equity of 0.00% beat Enzo Biochem's return on equity.

Company Net Margins Return on Equity Return on Assets
Enzo Biochem-75.34% -7.96% -5.49%
ATI Physical Therapy -7.79%N/A -3.87%

Summary

ATI Physical Therapy beats Enzo Biochem on 5 of the 9 factors compared between the two stocks.

Get ATI Physical Therapy News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATIP vs. The Competition

MetricATI Physical TherapyNursing & personal care facilities IndustryMedical SectorNYSE Exchange
Market Cap$4.54M$4.54M$5.52B$20.76B
Dividend YieldN/AN/A4.00%3.65%
P/E Ratio-0.06N/A28.2527.58
Price / Sales0.010.01411.1059.11
Price / Cash0.190.1924.9917.94
Price / Book-0.04N/A8.094.66
Net Income-$69.79M-$69.79M$3.25B$995.01M
7 Day PerformanceN/AN/A0.36%-0.38%
1 Month Performance1.98%1.98%7.70%6.21%
1 Year Performance-82.51%-82.51%32.74%11.21%

ATI Physical Therapy Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATIP
ATI Physical Therapy
N/A$1.03
flat
N/AN/A$4.54M$741.86M-0.065,600Upcoming Earnings
ENZ
Enzo Biochem
N/A$0.33
-14.8%
N/A-71.5%$17.03M$29.09M0.00520Gap Down
High Trading Volume
BRTX
Biorestorative Therapies
3.5153 of 5 stars
$1.72
+13.2%
$18.00
+946.5%
-4.8%$11.41M$400K-1.177
BGLC
BioNexus Gene Lab
0.4341 of 5 stars
$6.39
+7.8%
N/A-1.2%$10.65M$9.51M0.0030
MGRX
Mangoceuticals
N/A$1.54
+5.5%
N/A-98.1%$7.55M$620K-0.333
SSY
SunLink Health Systems
2.956 of 5 stars
$1.00
-2.0%
N/A+36.2%$7.04M$31.09M7.141,376
ACON
Aclarion
2.2237 of 5 stars
$7.61
-1.8%
$11,758.50
+154,413.8%
-99.7%$4.51M$50K0.007
DHAC
Digital Health Acquisition
N/A$1.17
-1.7%
N/A-70.1%$4.22MN/A0.002,021
NIVF
NewGenIvf Group
N/A$0.66
-24.0%
N/A-99.7%$3.75M$5.43M0.00N/AGap Down
OTRK
Ontrak
2.5104 of 5 stars
$0.44
-0.6%
$45.00
+10,188.1%
-84.9%$1.86M$10.85M-0.03250Gap Down
High Trading Volume
BACK
IMAC
N/A$0.07
-18.9%
N/A-93.8%$142K$72.05K0.00180Gap Down

Related Companies and Tools


This page (NYSE:ATIP) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners